Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Dec;63(6):1675–1684. doi: 10.1086/302145

A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1.

S H Pearce 1, T Cheetham 1, H Imrie 1, B Vaidya 1, N D Barnes 1, R W Bilous 1, D Carr 1, K Meeran 1, N J Shaw 1, C S Smith 1, A D Toft 1, G Williams 1, P Kendall-Taylor 1
PMCID: PMC1377639  PMID: 9837820

Abstract

Autoimmune polyendocrinopathy type 1 (APS1) is an autosomal recessive disorder characterized by autoimmune hypoparathyroidism, autoimmune adrenocortical failure, and mucocutaneous candidiasis. Recently, an autoimmune regulator gene (AIRE-1), which is located on chromosome 21q22.3, has been identified, and mutations in European kindreds with APS1 have been described. We used SSCP analysis and direct DNA sequencing to screen the entire 1,635-bp coding region of AIRE-1 in 12 British families with APS1. A 13-bp deletion (964del13) was found to account for 17 of the 24 possible mutant AIRE-1 alleles, in our kindreds. This mutation was found to occur de novo in one affected subject. A common haplotype spanning the AIRE-1 locus was found in chromosomes that carried the 964del13 mutation, suggesting a founder effect in our population. One of 576 normal subjects was also a heterozygous carrier of the 964del13 mutation. Six other point mutations were found in AIRE-1, including two 1-bp deletions, three missense mutations (R15L, L28P, and Y90C), and a nonsense mutation (R257*). The high frequency of the 964del13 allele and the clustering of the other AIRE-1 mutations may allow rapid molecular screening for APS1 in British kindreds. Furthermore, the prevalence of the 964del13 AIRE-1 mutation may have implications in the pathogenesis of the more common autoimmune endocrinopathies in our population.

Full Text

The Full Text of this article is available as a PDF (442.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen J., Björses P., Sandkuijl L., Perheentupa J., Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet. 1994 Sep;8(1):83–87. doi: 10.1038/ng0994-83. [DOI] [PubMed] [Google Scholar]
  2. Aaltonen J., Horelli-Kuitunen N., Fan J. B., Björses P., Perheentupa J., Myers R., Palotie A., Peltonen L. High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res. 1997 Aug;7(8):820–829. doi: 10.1101/gr.7.8.820. [DOI] [PubMed] [Google Scholar]
  3. Aasland R., Gibson T. J., Stewart A. F. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci. 1995 Feb;20(2):56–59. doi: 10.1016/s0968-0004(00)88957-4. [DOI] [PubMed] [Google Scholar]
  4. Ahonen P. Autoimmune polyendocrinopathy--candidosis--ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet. 1985 Jun;27(6):535–542. doi: 10.1111/j.1399-0004.1985.tb02037.x. [DOI] [PubMed] [Google Scholar]
  5. Ahonen P., Myllärniemi S., Sipilä I., Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990 Jun 28;322(26):1829–1836. doi: 10.1056/NEJM199006283222601. [DOI] [PubMed] [Google Scholar]
  6. Arulanantham K., Dwyer J. M., Genel M. Evidence for defective immunoregulation in the syndrome of familial candidiasis endocrinopathy. N Engl J Med. 1979 Jan 25;300(4):164–168. doi: 10.1056/NEJM197901253000403. [DOI] [PubMed] [Google Scholar]
  7. Björses P., Aaltonen J., Vikman A., Perheentupa J., Ben-Zion G., Chiumello G., Dahl N., Heideman P., Hoorweg-Nijman J. J., Mathivon L. Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet. 1996 Oct;59(4):879–886. [PMC free article] [PubMed] [Google Scholar]
  8. Canale V. C., Smith C. H. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr. 1967 Jun;70(6):891–899. doi: 10.1016/s0022-3476(67)80262-2. [DOI] [PubMed] [Google Scholar]
  9. Davies J. L., Kawaguchi Y., Bennett S. T., Copeman J. B., Cordell H. J., Pritchard L. E., Reed P. W., Gough S. C., Jenkins S. C., Palmer S. M. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994 Sep 8;371(6493):130–136. doi: 10.1038/371130a0. [DOI] [PubMed] [Google Scholar]
  10. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 1996 Mar 14;380(6570):152–154. doi: 10.1038/380152a0. [DOI] [PubMed] [Google Scholar]
  11. Drappa J., Vaishnaw A. K., Sullivan K. E., Chu J. L., Elkon K. B. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med. 1996 Nov 28;335(22):1643–1649. doi: 10.1056/NEJM199611283352204. [DOI] [PubMed] [Google Scholar]
  12. Farabaugh P. J., Schmeissner U., Hofer M., Miller J. H. Genetic studies of the lac repressor. VII. On the molecular nature of spontaneous hotspots in the lacI gene of Escherichia coli. J Mol Biol. 1978 Dec 25;126(4):847–857. doi: 10.1016/0022-2836(78)90023-2. [DOI] [PubMed] [Google Scholar]
  13. Finnish-German APECED Consortium An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997 Dec;17(4):399–403. doi: 10.1038/ng1297-399. [DOI] [PubMed] [Google Scholar]
  14. Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middleton L. A., Lin A. Y., Strober W., Lenardo M. J., Puck J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995 Jun 16;81(6):935–946. doi: 10.1016/0092-8674(95)90013-6. [DOI] [PubMed] [Google Scholar]
  15. Friedman T. C., Thomas P. M., Fleisher T. A., Feuillan P., Parker R. I., Cassorla F., Chrousos G. P. Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I. Am J Med. 1991 Dec;91(6):625–630. doi: 10.1016/0002-9343(91)90215-j. [DOI] [PubMed] [Google Scholar]
  16. Fukuhara Y., Sakuraba H., Oshima A., Shimmoto M., Nagao Y., Nadaoka Y., Suzuki T., Suzuki Y. Partial deletion of human alpha-galactosidase A gene in Fabry disease: direct repeat sequences as a possible cause of slipped mispairing. Biochem Biophys Res Commun. 1990 Jul 16;170(1):296–300. doi: 10.1016/0006-291x(90)91273-u. [DOI] [PubMed] [Google Scholar]
  17. HUNG W., MIGEON C. J., PARROTT R. H. A POSSIBLE AUTOIMMUNE BASIS FOR ADDISON'S DISEASE IN THREE SIBLINGS, ONE WITH IDIOPATHIC HYPOPARATHYROIDISM, PERNICIOUS ANEMIA AND SUPERFICIAL MONILIASIS. N Engl J Med. 1963 Sep 26;269:658–663. doi: 10.1056/NEJM196309262691303. [DOI] [PubMed] [Google Scholar]
  18. Hong R., Dibbell D. G. Cultured thymus fragment transplant in chronic candidiasis complicated by oral carcinoma. Lancet. 1981 Apr 4;1(8223):773–774. doi: 10.1016/s0140-6736(81)92640-4. [DOI] [PubMed] [Google Scholar]
  19. Houwen R. H., Baharloo S., Blankenship K., Raeymaekers P., Juyn J., Sandkuijl L. A., Freimer N. B. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet. 1994 Dec;8(4):380–386. doi: 10.1038/ng1294-380. [DOI] [PubMed] [Google Scholar]
  20. Hästbacka J., de la Chapelle A., Mahtani M. M., Clines G., Reeve-Daly M. P., Daly M., Hamilton B. A., Kusumi K., Trivedi B., Weaver A. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell. 1994 Sep 23;78(6):1073–1087. doi: 10.1016/0092-8674(94)90281-x. [DOI] [PubMed] [Google Scholar]
  21. Jorde L. B. Linkage disequilibrium as a gene-mapping tool. Am J Hum Genet. 1995 Jan;56(1):11–14. [PMC free article] [PubMed] [Google Scholar]
  22. KENNY F. M., HOLLIDAY M. A. HYPOPARATHYROIDISM, MONILIASIS, ADDISON'S AND HASHIMOTO'S DISEASES. HYPERCALCEMIA TREATED WITH INTRAVENOUSLY ADMINISTERED SODIUM SULFATE. N Engl J Med. 1964 Oct 1;271:708–713. doi: 10.1056/NEJM196410012711404. [DOI] [PubMed] [Google Scholar]
  23. Kendall-Taylor P., Lambert A., Mitchell R., Robertson W. R. Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease. Br Med J (Clin Res Ed) 1988 May 28;296(6635):1489–1491. doi: 10.1136/bmj.296.6635.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nagamine K., Peterson P., Scott H. S., Kudoh J., Minoshima S., Heino M., Krohn K. J., Lalioti M. D., Mullis P. E., Antonarakis S. E. Positional cloning of the APECED gene. Nat Genet. 1997 Dec;17(4):393–398. doi: 10.1038/ng1297-393. [DOI] [PubMed] [Google Scholar]
  25. Neufeld M., Maclaren N. K., Blizzard R. M. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981 Sep;60(5):355–362. doi: 10.1097/00005792-198109000-00003. [DOI] [PubMed] [Google Scholar]
  26. Nisticò L., Buzzetti R., Pritchard L. E., Van der Auwera B., Giovannini C., Bosi E., Larrad M. T., Rios M. S., Chow C. C., Cockram C. S. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet. 1996 Jul;5(7):1075–1080. doi: 10.1093/hmg/5.7.1075. [DOI] [PubMed] [Google Scholar]
  27. Pearce S. H., Trump D., Wooding C., Besser G. M., Chew S. L., Grant D. B., Heath D. A., Hughes I. A., Paterson C. R., Whyte M. P. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest. 1995 Dec;96(6):2683–2692. doi: 10.1172/JCI118335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Richman R. A., Rosenthal I. M., Solomon L. M., Karachorlu K. V. Candidiasis and multiple endocrinopathy. With oral squamous cell carcinoma complications. Arch Dermatol. 1975 May;111(5):625–627. [PubMed] [Google Scholar]
  29. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I. A., Debatin K. M., Fischer A., de Villartay J. P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995 Jun 2;268(5215):1347–1349. doi: 10.1126/science.7539157. [DOI] [PubMed] [Google Scholar]
  30. Sawcer S., Jones H. B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P. N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet. 1996 Aug;13(4):464–468. doi: 10.1038/ng0896-464. [DOI] [PubMed] [Google Scholar]
  31. Scott H. S., Heino M., Peterson P., Mittaz L., Lalioti M. D., Betterle C., Cohen A., Seri M., Lerone M., Romeo G. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol. 1998 Aug;12(8):1112–1119. doi: 10.1210/mend.12.8.0143. [DOI] [PubMed] [Google Scholar]
  32. Vyse T. J., Todd J. A. Genetic analysis of autoimmune disease. Cell. 1996 May 3;85(3):311–318. doi: 10.1016/s0092-8674(00)81110-1. [DOI] [PubMed] [Google Scholar]
  33. Wu J., Wilson J., He J., Xiang L., Schur P. H., Mountz J. D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996 Sep 1;98(5):1107–1113. doi: 10.1172/JCI118892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zlotogora J., Shapiro M. S. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet. 1992 Nov;29(11):824–826. doi: 10.1136/jmg.29.11.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet. 1993 Oct;30(10):857–865. doi: 10.1136/jmg.30.10.857. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES